Medios AG (MEDOF) Stock Forecast & Price Target

Compare

28 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MEDOF Analyst Ratings

Moderate Buy

2 Buy

0 Hold

0 Sell

Based on 2 analysts giving stock ratings to

Medios

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MEDOF Stock 12 Month Forecast

Average Price Target

$25.14

▲(73.26%Upside)

Based on 2 Wall Street analysts offering 12 month price targets for Medios AG in the last 3 months. The average price target is $25.14 with a high forecast of $29.72 and a low forecast of $20.57. The average price target represents a 73.26% change from the last price of $14.51.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","30":"$30","15.75":"$15.75","20.5":"$20.5","25.25":"$25.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":29.715322,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$29.72</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25.14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$25.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20.572146,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$20.57</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,15.75,20.5,25.25,30],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.52,15.688870923076923,16.857741846153846,18.02661276923077,19.195483692307693,20.364354615384617,21.533225538461537,22.70209646153846,23.870967384615383,25.039838307692307,26.20870923076923,27.377580153846154,28.546451076923077,{"y":29.715322,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.52,15.336923076923076,16.153846153846153,16.970769230769232,17.787692307692307,18.604615384615386,19.42153846153846,20.23846153846154,21.055384615384614,21.872307692307693,22.689230769230768,23.506153846153847,24.323076923076925,{"y":25.14,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.52,14.985549692307693,15.451099384615384,15.916649076923077,16.38219876923077,16.847748461538462,17.313298153846155,17.778847846153845,18.244397538461538,18.70994723076923,19.175496923076924,19.641046615384617,20.106596307692307,{"y":20.572146,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":15.59,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.25,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.74,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.23,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.31,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.58,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.69,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.86,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.71,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.88,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.19,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.5,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.52,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$29.72

Average Price Target$25.14

Lowest Price Target$20.57

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Michael KuhnDeutsche Bank

Deutsche Bank

$20.57

Buy

41.78%

Upside

Reiterated

05/14/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: SAB Biotherapeutics (NASDAQ: SABS), Medios AG (Other OTC: MEDOF) and Leap Therapeutics (NASDAQ: LPTX)

Michael HeiderWarburg Research

Warburg Research

$29.72

Buy

104.79%

Upside

Reiterated

05/13/25

Warburg Research Sticks to Their Buy Rating for Medios AG (MEDOF)

Alexander GalitsaHauck & Aufhaeuser

Hauck & Aufhaeuser

$25.14

Buy

73.29%

Upside

Reiterated

04/11/25

Hauck & Aufhaeuser Remains a Buy on Medios AG (MEDOF)

Matthias MaenhautKepler Capital

Kepler Capital

$27.43

Buy

89.04%

Upside

Reiterated

03/25/25

Kepler Capital Keeps Their Buy Rating on Medios AG (MEDOF)

Sam EnglandBerenberg Bank

Berenberg Bank

$40→$36.57

Buy

152.05%

Upside

Reiterated

03/21/25

Berenberg Bank Sticks to Their Buy Rating for Medios AG (MEDOF)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Michael KuhnDeutsche Bank

Deutsche Bank

$20.57

Buy

41.78%

Upside

Reiterated

05/14/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: SAB Biotherapeutics (NASDAQ: SABS), Medios AG (Other OTC: MEDOF) and Leap Therapeutics (NASDAQ: LPTX)

Michael HeiderWarburg Research

Warburg Research

$29.72

Buy

104.79%

Upside

Reiterated

05/13/25

Warburg Research Sticks to Their Buy Rating for Medios AG (MEDOF)

Alexander GalitsaHauck & Aufhaeuser

Hauck & Aufhaeuser

$25.14

Buy

73.29%

Upside

Reiterated

04/11/25

Hauck & Aufhaeuser Remains a Buy on Medios AG (MEDOF)

Matthias MaenhautKepler Capital

Kepler Capital

$27.43

Buy

89.04%

Upside

Reiterated

03/25/25

Kepler Capital Keeps Their Buy Rating on Medios AG (MEDOF)

Sam EnglandBerenberg Bank

Berenberg Bank

$40→$36.57

Buy

152.05%

Upside

Reiterated

03/21/25

Berenberg Bank Sticks to Their Buy Rating for Medios AG (MEDOF)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medios AG

1 Month

xxx

Success Rate

2/11 ratings generated profit

Average Return

-0.80%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 18.18% of your transactions generating a profit, with an average return of -0.80% per trade.

3 Months

xxx

Success Rate

5/17 ratings generated profit

Average Return

-3.61%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 29.41% of your transactions generating a profit, with an average return of -3.61% per trade.

1 Year

Michael HeiderWarburg Research

Success Rate

5/17 ratings generated profit

Average Return

-10.94%

reiterated a buy rating 3 months ago

Copying Michael Heider's trades and holding each position for 1 Year would result in 29.41% of your transactions generating a profit, with an average return of -10.94% per trade.

2 Years

xxx

Success Rate

5/17 ratings generated profit

Average Return

-35.71%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 29.41% of your transactions generating a profit, with an average return of -35.71% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MEDOF Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MEDOF has received 12 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MEDOF average Analyst price target in the past 3 months is 25.14.

Each month's total comprises the sum of three months' worth of ratings.

MEDOF Financial Forecast

MEDOF Earnings Forecast

Next quarter’s earnings estimate for MEDOF is $0.29 with a range of $0.29 to $0.29. The previous quarter’s EPS was $0.29. MEDOF beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.06% of the time in the same period. In the last calendar year MEDOF has Preformed in-line its overall industry.

MEDOF Sales Forecast

Next quarter’s sales forecast for MEDOF is $574.97M with a range of $574.97M to $574.97M. The previous quarter’s sales results were $552.90M. MEDOF beat its sales estimates 33.33% of the time in past 12 months, while its overall industry beat sales estimates 47.30% of the time in the same period. In the last calendar year MEDOF has Outperformed its overall industry.

MEDOF Stock Forecast FAQ

What is MEDOF’s average 12-month price target, according to analysts?

Based on analyst ratings, Medios AG’s 12-month average price target is 25.14.

What is MEDOF’s upside potential, based on the analysts’ average price target?

Medios AG has 73.26% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MEDOF a Buy, Sell or Hold?

Medios AG has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.

What is Medios AG’s price target?

The average price target for Medios AG is 25.14. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $29.72 ,the lowest forecast is $20.57. The average price target represents 73.26% Increase from the current price of $14.51.

What do analysts say about Medios AG?

Medios AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.

How can I buy shares of MEDOF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Medios AG (MEDOF) Stock Forecast & Price Target

MEDOF Analyst Ratings

MEDOF Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Medios AG

MEDOF Analyst Recommendation Trends

MEDOF Financial Forecast

MEDOF Earnings Forecast

MEDOF Sales Forecast

MEDOF Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts